Last update 22 Feb 2024
Novo Nordisk A/S

Novo Nordisk A/S

Public Company|
1923|
Hovedstaden, Denmark
|
50,000-100,000
| CPH: NOVO|

Overview

Tags

Endocrinology and Metabolic Disease
Digestive System Disorders
Cardiovascular Diseases
Small molecule drug
Small interfering RNA
Hormone

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Small molecule drug38
Small interfering RNA20
Hormone16
Unknown7
Synthetic peptide7

Pipeline

Pipeline Snapshot as of 25 Feb 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
3
34
Preclinical
Phase 1 Clinical
35
11
Phase 2 Clinical
Phase 3 Clinical
8
1
NDA/BLA
Approved
26
116
Other
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free